Conventional polymerase chain reaction (PCR) |
—— |
gE gene |
Result in <5 h |
Various tissue |
[119,121] |
Duplex droplet digital PCR (ddPCR) assary |
4.75 copies/µL |
Both gE and gB genes |
Result in <2 h |
Lung, brain, liver and spleen |
[124] |
SYBR green I-based duplex real-time PCR assay |
37.8 copies/μL |
gE gene |
Result within 50 min |
Hearts, livers, spleens, lungs, kidneys, brains and lymph nodes |
[118] |
Real-time recombinase-aided amplification assay (RAA) |
Three 50% TCID50
|
gE gene |
Result in 75 min |
Lung, lymph node, tonsil and spleen |
[125] |
Triplex real-time PCR |
0.5 TCID50 for classical strains, 0.2 TCID50 for variant strains and 0.05 TCID50 for vaccine strains |
gE and gI genes |
Result within 1 h |
PRV strains |
[127] |
Probe-based fluorescence melting curve analysis (FMCA) |
1 × 100 copies per reaction |
gC and gE genes |
Result in <2 h |
PRV strains |
[120] |
Loop-mediated isothermal amplification (LAMP) assay |
10 copies per sample |
gE and gG genes |
Result in <2 h |
PRV strains and clinical tissue samples |
[122] |
Duplex nanoparticle-assisted polymerase chain reaction (nanoPCR) |
6 copies/μL |
gE gene |
Result in 80 min |
The recombinant plasmids pET30a-PRV-gE and pUC57-PBoVNS1 |
[128] |
Real-time quantitative PCR (RT-qPCR) |
Oral fluid of 53% and nasal swab of 70% |
gB gene |
Result in <1 h |
Oral fluid and nasal swab |
[129] |
Metagenomic next-and third-generation sequencing (mNGS/TGS) |
—— |
Short- and long-read sequencing |
—— |
Brains |
[137] |
Real-time fluorescent detection (real-time RPA assay) |
100 copies per reaction |
gD gene |
Result within 20 min |
Tissue |
[130] |
Lateral flow dipstick (RPA LFD assay) |
160 copies per reaction |
gD gene |
Result within 20 min |
Tissue |
[130] |
Magnetic beads-based chemiluminescent assay |
100 μmol/5 pM |
—— |
Result in 20 min |
Serum samples |
[131] |